A citation-based method for searching scientific literature

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau, Robert A Soslow, Raji Ganesan, Xavier Matias-Guiu, Esther Oliva, Beth T Harrison, David N Church, C Blake Gilks, Tjalling Bosse. J Pathol 2020
Times Cited: 91



Interpretation of somatic POLE mutations in endometrial carcinoma.
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, Jessica N McAlpine, Remi Nout, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau, Tjalling Bosse, David N Church, C Blake Gilks. J Pathol 2020
Times Cited: 87




List of shared articles



Times cited

Improving response to progestin treatment of low-grade endometrial cancer.
Eva Baxter, Donal J Brennan, Jessica N McAlpine, Jennifer J Mueller, Frédéric Amant, Mignon D J M van Gent, David G Huntsman, Robert L Coleman, Shannon N Westin, Melinda S Yates,[...]. Int J Gynecol Cancer 2020
9

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Carien L Creutzberg, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Virchows Arch 2021
23

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
Naveena Singh, Anna M Piskorz, Tjalling Bosse, Mercedes Jimenez-Linan, Brian Rous, James D Brenton, C Blake Gilks, Martin Köbel. J Pathol 2020
69

Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Giovanni Scambia, Domenica Lorusso. Front Oncol 2021
3

Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Anne M Kolehmainen, Annukka M Pasanen, Riitta L Koivisto-Korander, Ralf C Bützow, Mikko J Loukovaara. Eur J Obstet Gynecol Reprod Biol 2021
4

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
252

Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification.
F Siegenthaler, K Lindemann, E Epstein, T T Rau, D Nastic, M Ghaderi, F Rydberg, M D Mueller, J Carlson, S Imboden. Gynecol Oncol 2022
0

The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers.
Silvana Talisa Wijaya, Natalie Yl Ngoi, David Sp Tan. Best Pract Res Clin Obstet Gynaecol 2022
0

Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience.
Kelly A Devereaux, Julianna J Weiel, Jennifer Pors, David F Steiner, Chandler Ho, Vivek Charu, Carlos J Suarez, Malte Renz, Elisabeth Diver, Amer Karam,[...]. Mod Pathol 2022
1

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, Dawn Cochrane, Heidi Britton, Annick Pina, Claudine Storness-Bliss, David Farnell, Leo Huang, Kathryn Shum,[...]. Gynecol Oncol 2020
33

[Endometrial carcinomas in 2021: What to say and what to do?]
Pierre-Alexandre Just, Catherine Genestie. Ann Pathol 2022
0

Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Amy Jamieson, Lisa M Barroilhet, Jessica N McAlpine. Cancer 2022
0

A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.
Ilaria Betella, Caterina Fumagalli, Paola Rafaniello Raviele, Gabriella Schivardi, Luigi Antonio De Vitis, Maria Teresa Achilarre, Alessia Aloisi, Annalisa Garbi, Matteo Maruccio, Vanna Zanagnolo,[...]. Int J Gynecol Cancer 2022
0

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Radiother Oncol 2021
24

Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives.
Alessandra Giustozzi, Vanda Salutari, Elena Giudice, Lucia Musacchio, Caterina Ricci, Chiara Landolfo, Maria Teresa Perri, Giovanni Scambia, Domenica Lorusso. Biology (Basel) 2021
1

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions.
Matthias Alexa, Annette Hasenburg, Marco Johannes Battista. Cancers (Basel) 2021
12

Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapy.
Yubo Zhang, Ruiye Yang, Chunyu Xu, Yanqin Zhang, Mengqi Deng, Di Wu, Fan Tang, Xinyu Liu, Yiding Han, Yang Zhan,[...]. Pathol Res Pract 2022
0

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines.
Mikko Loukovaara, Annukka Pasanen, Ralf Bützow. Cancers (Basel) 2022
2

Molecular classification of endometrial carcinoma: a clinically oriented review.
Mikko Loukovaara, Annukka Pasanen, Ralf Bützow. J Clin Pathol 2022
0

Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis.
Eva Coll-de la Rubia, Elena Martinez-Garcia, Gunnar Dittmar, Antonio Gil-Moreno, Silvia Cabrera, Eva Colas. J Clin Med 2020
29

Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features.
Amy Joehlin-Price, Jessica Van Ziffle, Nancy K Hills, Nicholas Ladwig, Joseph T Rabban, Karuna Garg. Am J Surg Pathol 2021
11

New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Angela Santoro, Giuseppe Angelico, Antonio Travaglino, Frediano Inzani, Damiano Arciuolo, Michele Valente, Nicoletta D'Alessandris, Giulia Scaglione, Vincenzo Fiorentino, Antonio Raffone,[...]. Cancers (Basel) 2021
27

Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.
Vivian S Park, Meijuan J S Sun, Wesley D Frey, Leonard G Williams, Karl P Hodel, Juliet D Strauss, Sydney J Wellens, James G Jackson, Zachary F Pursell. NAR Cancer 2022
0

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer.
Anne Kolehmainen, Annukka Pasanen, Taru Tuomi, Riitta Koivisto-Korander, Ralf Bützow, Mikko Loukovaara. PLoS One 2020
7

Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Tilman T Rau, Eva Bettschen, Carol Büchi, Lucine Christe, Amanda Rohner, Michael D Müller, Joseph W Carlson, Sara Imboden, Inti Zlobec. Mod Pathol 2021
13

Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study.
Jasper Victoor, Sara Vander Borght, Lien Spans, Stefan Lehnert, Hilde Brems, Annouschka Laenen, Ignace Vergote, Toon Van Gorp, Els Van Nieuwenhuysen, Sileny Han,[...]. Gynecol Oncol 2021
0

Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.
Eun Young Kang, Nicholas Jp Wiebe, Christa Aubrey, Cheng-Han Lee, Michael S Anglesio, Derek Tilley, Prafull Ghatage, Gregg S Nelson, Sandra Lee, Martin Köbel. J Pathol Clin Res 2022
1

Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan.
Mahina Monsur, Munekage Yamaguchi, Hironori Tashiro, Kumiko Yoshinobu, Fumitaka Saito, Chimeddulam Erdenebaatar, Chenyan Li, Yutaka Iwagoi, Takashi Ohba, Ken-Ichi Iyama,[...]. Med Mol Morphol 2021
1

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
135

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma.
Mikko Loukovaara, Annukka Pasanen, Ralf Bützow. Cancers (Basel) 2021
1

POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.
Laura Casey, Naveena Singh. Int J Gynecol Pathol 2021
12

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Pauline Krämer, Aline Talhouk, Mary Anne Brett, Derek S Chiu, Evan S Cairns, Daniëlla A Scheunhage, Rory F L Hammond, David Farnell, Tayyebeh M Nazeran, Marcel Grube,[...]. Clin Cancer Res 2020
22

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer.
Gilhyang Kim, Song Kook Lee, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim, Hyojin Kim. J Gynecol Oncol 2022
0

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.
Jutta Huvila, Katri Orte, Paula Vainio, Tuukka Mettälä, Titta Joutsiniemi, Sakari Hietanen. Hum Pathol 2021
4

Adjuvant Therapy for High-risk Endometrial Carcinoma.
J Perera, P Hoskin. Clin Oncol (R Coll Radiol) 2021
1

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
Amy Jamieson, Tjalling Bosse, Jessica N McAlpine. Ther Adv Med Oncol 2021
15

ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma.
Ikumi Kitazono, Yusuke Kobayashi, Toshiaki Akahane, Tomomi Yamaguchi, Shintaro Yanazume, Sachio Nohara, Ippei Sakamoto, Kazuhiro Tabata, Takashi Tasaki, Hiroaki Kobayashi,[...]. Pathol Res Pract 2022
1

TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.
Jonna Similä-Maarala, Piret Soovares, Annukka Pasanen, Terhi Ahvenainen, Pia Vahteristo, Ralf Bützow, Heini Lassus. Gynecol Oncol 2022
1

Endometrial cancer.
Emma J Crosbie, Sarah J Kitson, Jessica N McAlpine, Asima Mukhopadhyay, Melanie E Powell, Naveena Singh. Lancet 2022
5

Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives.
Ana Oaknin, Alicia León-Castillo, Domenica Lorusso. Curr Opin Oncol 2020
5

Endometrial Cancer: Transitioning from Histology to Genomics.
Cristina Mitric, Marcus Q Bernardini. Curr Oncol 2022
1

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
Jessica N McAlpine, Derek S Chiu, Remi A Nout, David N Church, Pascal Schmidt, Stephanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y Brucker,[...]. Cancer 2021
15

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.
Shuangni Yu, Zezheng Sun, Liju Zong, Jie Yan, Mei Yu, Jie Chen, Zhaohui Lu. J Gynecol Oncol 2022
2

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M de Boer, Tjalling Bosse, Carien L Creutzberg. Int J Gynecol Cancer 2021
16


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy